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Summary.-Thirteen lymphomas consisting of one particular cell type were selected
from 135 cases of non-Hodgkin's lymphoma. The lymphoma cells were mainly
characterized by irregularly shaped nuclei and faintly stained cytoplasm. The
growth pattern of the tumour was diffuse. Immunological phenotyping of suspended
cells showed that the tumour cells, irrespective of whether they were isolated from
lymphoma tissue or from peripheral blood of leukaemic cases, bore a dense layer
of surface immunoglobulin, lacked cytoplasmic immunoglobulin and receptors for
mouse erythrocytes, and expressed both complement-receptor subtypes (i.e., recep-
tors for C3b and C3d) in all but one case. The exceptional case was C3b receptor-
positive and C3d receptor-negative. The number of IgG-Fc receptor-bearing cells
was usually small. There was a consistently small proportion of non-malignant
T cells in the tumour tissue.
A comparison of the properties of these lymphomas with those of other types of
non-Hodgkin's lymphoma and of non-malignant lymphoid cells, shows that the
cells of this type of lymphoma (a) differ morphologically and/or immunologically
from the cells of all other known types of non-Hodgkin's lymphoma and (b)
resemble centrocytes (cleaved follicular-centre cells) of reactive germinal centres.
Thus, this type of lymphoma appears to be an entity that is closely related to, or
even derived from, centrocytes.
IN REACTIVE germinal centres, there
are 2 main morphological types of
lymphoid germinal-centre cells (GCC):
(1) Centroblasts medium-sized or
large cells with a round or oval, pale
nucleus containing 2-3 nucleoli, usually
located at the nuclear membrane; cyto-
plasm is sparse and intensely basophilic
(Lennert, 1957, 1961).
(2) Centrocytes small or medium-
sized cells with a cleaved or irregularly
shaped nucleus; cytoplasm is usually
sparse and very weakly basophilic and
thus difficult to recognize in sections
(Lennert, 1964). Except in newly formed
germinal centres, centrocytes are the
predominant cells.
Both types of GCC are B cells. Most
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GCC express Ia-like antigen (own un-
published data). Only some GCC bear
surface immunoglobulin (SIg) (Gutman
& Weissman, 1972; Goldschneider &
McGregor, 1973; Hoffmann-Fezer et al.,
1976; own unpublished data) and a few
GCC contain cytoplasmic immunoglobulin
(CIg); these usually resemble centrocytes
(Stein & Tolksdorf in press). Character-
istically, GCC express complement recept-
ors, whichwasfirstdemonstrated by Dukor
et al. (1970). Those investigators showed
that erythrocyte-antibody-complement
complexes (EAC) prepared with whole
mouse serum (EACmouse) as complement
source adhered exclusively to germinal
centres. Recently, our research group
analysed the presence and distribution of
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the complement-receptor subtypes (recep-
tors for C3b and C3d) in reactive lymphoid
tissue (Stein et al., 1978b). We found that
GCC bear both complement-receptor sub-
types. The expression of both subtypes
proved to be highly characteristic of
GCC.
It has become evident that reactive
germinal centres have a neoplastic equi-
valent, viz.: a lymphoma that is composed
of both centroblast-like and centrocyte-
like cells with a predominance of centro-
cyte-like cells, as have most germinal
centres (Lennert, 1964, 1973; Lennert
et al., 1975a, b). In 95% of the cases, the
tumour shows a follicular growth pattern
and has thus been called "follicular
lymphoma". Recently, the term "malig-
nant lymphoma (ML) centroblastic/
centrocytic" was introduced (Gerard-
Marchant et al., 1974; Lennert et al.,
1975a) because the cytological composition
of the lymphoma is more consistent than
the follicular growth pattern (which was
absent in about 5% of our cases). Doubts
about the close relationship between this
tumour and germinal centres were elimin-
ated by the demonstration of complement
receptors on the neoplastic follicles, with
a distribution and density similar to that
of the complement receptors on reactive
germinal centres (Jaffe et al., 1974; Stein,
1976). More convincing arguments in
favour of the close relationship between
centroblastic/centrocytic lymphoma (CB/
CC) and germinal centres were provided
by the similar expression and distribution
of the 2 complement-receptor subtypes
in CB/CC and follicular hyperplasia (Stein
et al., 1978a, b).
In this paper, we describe a type of
lymphoma that is probably also derived
from GCC, but, in contrast to CB/CC, is
composed of only one type of GCC, i.e., of
cells that resemble centrocytes of reactive
germinal centres. We shall present
immunological data that confirm the close
relationship between the centrocyte-like
tumour cells and reactive centrocytes.
Preliminary data onthistypeoflymphoma
have been reported in a number of
previous papers (Lennert et al., 1975a, b;
Stein, 1976, 1978; Lennert & Mohri, 1978;
Stein etal., 1978a, 1979; Stein & Tolksdorf,
1979).
MATERIALS AND METHODS
Source and handling of material.-Thirteen
patients with centrocytic lymphoma, as
defined by the criteria given below (see
Results) were selected from a series of
135 patients with non-Hodgkin's lymphoma,
from which tumour cells were studied by
immunological methods. Lymphnode biopsies
were available in 9 cases, together with
peripheral blood in 1 of these cases, and
peripheral blood was available in the other
4 cases. All 5 cases in which we investigated
peripheral blood showed leukaemia (total
leucocyte counts are given in Table II). After
density-gradient centrifugation (see below),
all lymphocyte suspensions contained a
significant proportion ( >85%) of tumour
cells, as established by cytological and
immunological analyses.
Lymphnode biopsies were also obtained
from 14 patients with CB/CC, 15 with chronic
lymphocytic leukaemia of B type (B-CLL),
and 1 with prolymphocytic leukaemia of
B type (B-PLL). Peripheral blood was
available from 4 other patients with B-PLL.
These disorders were diagnosed by the
criteria given below (see Results).
Biopsy specimens obtained in Kiel were
cut into 3 pieces immediately after surgical
removal. Imprints were made from the
fresh cut surface. One piece was fixed in
formalin, cryosections were prepared from
the second piece, and a cell suspension was
prepared from the third piece. Biopsies
taken in hospitals outside Kiel (up to 700 km
away) were cut into 2 pieces after surgical
removal and imprints were made from the
fresh cut surface. One piece was placed in
formalin and the other in sterile tissue-
culture medium cooled with ice in a Dewar
bottle. The material was then sent to our
laboratory by over-night rail express. After
arrival in the morning, the piece in tissue-
culture medium was cut into 2 pieces when
it was large enough. One of these 2 pieces
was used for preparing cryosections and the
other for cell suspensions.
Blood samples were supplemented with
heparin (1 ml Thrombo vetren®, Promonta,
Hamburg, Germany). Heparinized blood
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samples from outside Kiel were sent by rail
express to our laboratory in 20 ml syringes
cooled with ice in a Dewar bottle.
Light microscopy. The piece of tissue that
had been fixed in 100% formalin wasembedded
in paraffin. Sections were cut at 4 ,um and
stained with haematoxylin and eosin (H
and E), Giemsa (Merck, Darmstadt, Germany)
periodic-acid Schiff (PAS) and silver impreg-
nation (Goinori). Tissue imprints were stained
with Pappenheim. For cytological character-
ization of suspended cells and cytological
identification of cells subjected to rosette
assays, cytocentrifuge slides were prepared
and stained with Pappenheim.
Frozen sections. 10 um cryostat sections
were cut from 1 part of the fresh unfixed
biopsy specimen and lyophilized at 10-2
mmHg and -68°C. The lyophilized sections
wNere kept at -90TC until use.
Cell suspensions.- One unfixed piece of
the biopsy specimen was finely minced and
passed through a plastic mesh. The filtered
lymphoid cells w%Nere then separated from red
blood cells, cell debris and interstitial tissue
components, by density-gradient centri-
fugation (Boyum, 1968). After 2 washings,
the viability of the cells w%as measured with
the trypan-blue-exclusion test. Only suspen-
sions with 750/0 viable cells were used for the
immunological assays. The lymphoid cell
fraction was also obtained from blood
samples by density-gradient centrifugation.
Preparation of EAC intermediate corn-
plexes.-EAC1-3b and EACI-3d were pre-
pared as previously described (Stein et al.,
1-978b), using trypsinized sheep erythrocytes
(sheep E) rabbit anti-erythrocyte antibodies
of the IgM type, and functionally purified
human complement components (Cordis.
Miami, Florida, USA).
Assay for binding of EAC3b and EAC3d to
cells in suspensions and frozen sections.-
Target cells (0 75 x 106) were incubated with
3-0 x 107 EAC in a total volume of 450 ,ul
TC-199 medium for 10 min at 37°C and then
centrifuged at 200 g for 30 min. The cells
w-ere then gently resuspended and kept on
ice until counting. Any cell binding 3 or
more indicator cells was scored as positive.
To achieve reproducible and constant
binding of EAC intermediates on tissue
sections, a flat chamber wras built over the
lyophilized sections and filled with IgM-EA,
EAC-3b, or EAC-3d, as described by Stein
et al. (1978b). The slides with sealed chambers
were then centrifuged at 300 g for 8 min in a
swinging rotor. The slides were washed
several times in phosphate-buffered saline
to remove non-adherent red blood cells.
The resultant preparations were fixed for
10 min in formalin-methanol (1: 9 vol/vol)
stained with H. and E. and examined by
transmission and dark-field light microscopy.
Preparation of IgG-EA.-IgG-EA was
prepared by incubating ox erythrocytes
(ox E) in a rabbit anti-ox-E serum, which
had a low ox E agglutination titre (1:4) and
a high haemolysis titre (1:2000), at 37°C for
30 min. The rabbit serum, which was rich in
IgG antibodies directed against ox E, was
raised by immunizing rabbits once a week
i.v. with 1010 ox E for a total of 3 months.
Out of 5 anti-ox-E sera, one had the desired
properties.
Assay for binding of IgG-EA.-The same
procedure as described above for binding of
EAC was used.
Mouse-erythrocyte rosette assay.-The assay
of Gupta et al. (1976) was applied. Briefly,
1-5 x 106 target cells, either untreated or
pretreated with neuraminidase of Clostridium
perfringens origin (Sigma, Munich. Germany)
were mixed with 107 mouse erythrocytes
(mouse E) and 25 ,ul foetal calf serum (heat-
inactivated and absorbed with mouse E)
in a total volume of 175 ,ul. The mixture
was centrifuged at 200 g for 5 min at roonm
temperature, followed by incubation under
slight agitation at 28°C for 1 h. The pellet
was gently resuspended by rotating the test
tube around its long axis. Any cell that
bound 3 or more mouse E was scored as
positive.
Sheep-erythrocyte rosette assay.-The pro-
cedure described by Seiler et al. (1972) was
followed, using sheep E treated with
neuraminidase of Vibrio cholerae origin
(Bebring, Marburg, Germany).
Ia-like antigen.-Ia-like antigen was
demonstrated by indirect fluorescence as
described by Vossen (1975). Anti-Ta-like
serum was obtained from Alpha Gamma
Labs (Sierra Madre, California, U.S.A). The
characteristics of the antiserum have been
described in detail elsewhere (Billing et al.,
1976). Our own control experiments showed
that the anti-la-like serum positively stained
B cells, but not T cells. Goat anti-rabbit IgG
conjugated with rhodamine isothiocyanate
(RHITC; Nordic, Tilburg, The Netherlands)
wTas used as the second reagent at a dilution
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of 1:40. When the first reagent wras omitted,
this goat anti-rabbit IgG-RHITC conjugate
gave completely negative staining results in
all tests at a dilution of 1:40.
Surface immunoglobulin. SIg was detected
by direct immunofluorescence, using fluor-
escein isothiocyanate (FITC)- and RHITC-
IgG conjugates directed against human Ig
chains (Nordic, Tilburg, The Netherlands).
The specificity of the conjugates was tested
by staining fixed cells from multiple myeloma
and Waldenstr6m's macroglobulinaemia with
a known type of Clg.
Cytoplasmic imnmunoglobulin.-CIg w-as
demonstrated on paraffin sections by means
of the enzyme-bridge method of Sternberger
et al. (1970) as modified by Taylor (1974).
The procedure has been described in detail by
Papadimitriou et al. (1978).
RESULTS
Morphologicalfindings
Histology. In the 9 cases investigated,
the normal architecture ofthe lymph node
was completely replaced by lymphoma
cells. All cases showed a diffuse growth
pattern. Numerous small vessels (capil-
laries and arterioles) were visible among
the tumour cells. Epithelioid venules
were generally absent. The small vessels
were often surrounded by sheets of hyalin
material. Thick fibres were seen, especially
around the vessels.
In all cases, the vast majority of cells
were small or medium-sized centrocyte-
like cells (Fig. la). Cytoplasm was sparse
and hardly visible. The cleaved orindented
nuclei contained relatively sparse chroma-
tin and often displayed one, or sometimes
up to 3 small central nucleoli (Fig.
lb-d). All the tumours were completely
devoid of centroblast-like cells and follicle
mantle lymphocyte-like cells. In 2
tumours a small number of plasma cells
of the Marschalko type, wbich were
obviously reactive (polyclonal Jg pattern)
were present in small foci and were also
scattered throughout the lymph node.
In all other cases few apparently reactive
plasma cells could be identified.
Cytology. Cytological examination was
made on tissue imprints and cytocentri-
fuge slides prepared from tumour-cell
suspensions. The typical cytological fea-
tures of the tumour cells were clearly
visible in the cytocentrifuge slides, usually
much better than in lymphnode imprints.
The nuclei of most tumour cells showed
a characteristically irregular shape and
were cleaved or sometimes even lobed
(Fig. 2). They contained moderately
condensed chromatin and usually up to
3 small or medium-sized pale nucleoli,
which were often surrounded by a distinct
rim of well-condensed chromatin. The
cells had only a small amount ofpale-blue
cytoplasm. The tumour cells isolated
from peripheral blood showed identical
cytological features.
Immunologicalfindinys (Tables I andII )
Surface immunoglobulin.-In every case
studied, SIg was present on a large
proportion of the tumour cells (Table I).
The fluorescent staining for SIg was
usually very intense. Specification of the
light chains showed a restriction to one
light-chain type in 6 (K in 5 and A in
one case) ofthe 9 cases tested. In the other
3 cases, both light-chain types were
detectable on tumour cells. Heavy chains
(t , 8) y, and o) were specified in 4 cases. In
one case, we found none of the specified
heavy chains, although most of the
tumour cells showed intense staining
for K. In the other 3 cases, both pu and y
chains were demonstrable on tumour
cells. Two of the 3 ,u- and y-positive cases
showed staining for both K and A. In the
third case, the SIg was restricted to K.
Delta chains were absent from a vast
majority of the tumour cells in all 4 cases.
Cytoplasmic immunoglobulin. In all 9
cases investigated, the tumour cells were
consistently negative for CIg (Table II).
In 2 cases, there were a few ,u- or y-
positive plasma cells of the Marschalko
type, which were polyclonal, since they
were not restricted to one light-chain
type.
Ia-like antigen. Ia-like antigen was
present on a variable proportion (50-95%0)
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(a)
(e)
(b)
(d)
FIG. 1.-Histological appearance of 4 different cases of centrocytic lymphoma. (a) At intermediate
magnification (x 650) the relatively uniform cellular composition of the tumour is evident. The
tumour cells have irregularly shaped or cleaved nuclei; cytoplasm is not, or only barely, visible.
Centroblasts are completely absent. The arrow indicates a dendritic reticulum cell. Giemsa. (b-d)
These high-power photomicrographs (x 1050) illustrate the variation in size of the tumour cells
between 3 cases, and show the nuclear features in detail. Giemsa.
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I
FiG. 2.-Centrocytic lymphoma. The typical cytological features shown in Fig. 1 are easily recognized
on cytocentrifuge slides. Tumour cells have a deeply cleaved or even lobed nucleus, sparse cyto-
plasm, and 1-2 small distinct nucleoli. A residual non-neoplastic lymphocyte is seen in the
middle of the field. Pappenheim. x 875.
TABLE I.-Stainingfor surface immunoglobulin in 11 cases of centrocytic lymphoma
Case
No
3
4
5
6
7
8
9
10
11
12
13
Test
specimen*
LN
LN
LN
PB
LN
LN
LN
LN
PB
PB
PB
PB
IgM IgD IgG IgA IgE x A Polyvalent
(%) (/) (%) (%) (%) (0) (%) (0)
83 0 80 0 0 50 46 95
65 0 40 0 0 67 77 98
78
87 7 85 0 0 68 0 80
0 3 0 56 2
65
20 15
85
100 31 100
8 62 84
94 3 70
22 8 75
* LN =lymph node. PB =peripheral blood.
of the tumour cells from the 4 cases rosette-forming cells was not significantly
tested. increased (means 5.7% and 3.3%, respec-
Mouse erythrocyte rosette formation.- tively). The highest single value obtained
The proportion of mouse-E-binding was 17%.
tumour cells from both lymph nodes and IgG-Fc receptor.-The proportion of
peripheral blood was,-consistently small IgG-Fc receptor-bearing cells was gener-
(means 0.5% and 2%, respectively). Even ally small. Only 3 cases showed IgG-EA
after pretreatment of the tumour cells formation by about half of the tumour
with neuraminidase, the proportion of cells.
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Complement receptors and complement-
receptor subtypes.-Complement receptors
were demonstrable by EAC-rosette assay
in all 11 cases tested. Specification of the
complement-receptor subtypes (C3b and
C3d) revealed that both subtypes were
present on most of the suspended cells,
from all but one case. In the exceptional
case, EAC3b-binding cells predominated
in the lymphnode cell suspension, whereas
about equal proportions of EAC3b- and
EAC3d-binding cells were found among
the circulating neoplastic cells (Table II,
case 5). Altogether, the mean percentage
ofEAC3b-binding cells (62%) was slightly
higher than that of EAC3d rosette-
forming cells (56%) in lymphnode suspen-
sions. In the 4 cases showing a leukaemic
blood picture, analysis of the leukaemic
blood cells revealed 56% EAC3b- and 57%
EAC3d-binding cells. Cytological evalu-
ation of the rosette-forming cells of
cytocentrifuge slides demonstrated the
typical morphological features of small or
medium-sized cleaved cells described
above.
The adherence of EAC3b and EAC3d
to frozen sections was investigated in
4 cases. Both EAC3b and EAC3d adhered
to the sections in 3 of them. In the fourth
case, only adherence of EAC3b was
demonstrable. The adherent EAC were
distributed in a nodular pattern in all
4 cases.
Sheep erythrocyte rosette formation.-
The percentage of cells showing sponta-
neous sheep E-rosette formation was
consistently low (means 7% of suspended
lymphnode cells and 8% of the mono-
nuclear-cell fraction from leukaemic cases)
never exceeding 14%. On cytological
examination, the sheep E-binding cells
were identifiable as small lymphocytes.
Tumour cells failed to bind sheep E.
Differential diagnosis
We compared the findings in centro-
cytic lymphoma with the results of
morphological and immunological investi-
gations on a total of 34 cases of 3 types of
non-Hodgkin's lymphoma that may be
confused with centrocytic lymphoma:
CB/CC (14), B-CLL (15), and B-PLL (5).
Histology.-CB/CC, which is roughly
equivalent to follicular lymphoma,
imitates follicular hyperplasia. Centro-
blasts and centrocytes always proliferate
side by side, but with a predominance of
centrocytes. In B-CLL, the proliferating
cells are lymphocytes and a few larger
cells, which are usually grouped together
to form light-appearing areas that are
highly characteristic of B-CLL. Such light
areas are not seen in T-CLL. We diagnose
B-PLL by the criteria given by Galton
et al. (1974). Two out of the 5 cases of
B-PLL revealed tartrate-resistant acid-
phosphatase activity in a variable pro-
portion of the leukaemic cells.
Immunological findings.-The immuno-
logical data on CB/CC, B-CLL, B-PLL,
and centrocytic lymphoma are summar-
ized in Table III.
Surface immunoglobulin.-Thirteen
cases of CB/CC were investigated for the
presence of SIg. All cases were positive,
with a mean of 67% reactive cells among
the suspended lymphoma cells. The fluor-
escence was usually easily detectable.
Twelve cases ofB-CLL were analysed and
all showed positive SIg staining, with a
mean of 60% of the suspended cells. The
fluorescence was generally weak and often
barely detectable. In all 5 cases ofB-PLL,
a large proportion of the suspended cells
(mean 86%) showed bright fluorescence
when stained with anti-Ig sera.
Cytoplasmic immunoglobulin.-Thirteen
cases ofCB/CC were tested for CIg. In all,
at least a few plasma cells with positive
staining for both light chain types (K
and A) were found in parafollicular
regions. The tumour cells in the neoplastic
follicles were completely negative in all
but 2 cases, in which a few intrafollicular
cells, whose nuclei were identical to those
of the CIg- intrafollicular cells, showed
positive staining that was definitely
restricted to one light-chain type. In all
15 cases of B-CLL, the tumour cells were
CIg-. Two cases of B-PLL were tested for
CIg and both were also negative.
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Ia-like antigen.-In the 3 CB/CC cases
tested, a mean of 62% of the suspended
tumour cells reacted with antiserum
specific for HL-B antigen (Ia-like antigen).
The 3 tested cases of B-CLL showed a
mean of 48% positively stained tumour
cells. Two cases of B-PLL revealed a
mean percentage of 60% positively
reacting cells.
Mouse erythrocyte rosette formation.-In
14 cases of CB/CC, the mean proportion
of mouse E rosette-forming cells was 15%
of the suspended tumour cells. Pretreat-
ment of the lymphocytes with neuramin-
idase in 13 cases increased the mean to
29%. The mean percentage of mouse E
rosette-forming cells in 15 cases of B-CLL
was 44% without, and 62% with pre-
treatment of the lymphocytes with
neuraminidase. Five cases of B-PLL were
tested without and with pretreatment of
the lymphocytes with neuraminidase. The
mean percentage of mouse E rosette-
forming cells was 2% and 7%, respec-
tively.
IgG-Fc receptor.-In the 12 cases of
CB/CC tested, the proportion of cells
forming rosettes with IgG-coated ox E
was generally small (mean: 15%). Eight
cases were tested with FITC-conjugated
IgG aggregates and a mean of 10% of
the cells showed positive fluorescence.
Fourteen cases of B-CLL were investi-
gated with ox E coated with IgG. The
mean percentage of rosette-forming cells
was 19%. With aggregated IgG, the mean
percentage ofpositively reacting cells was
higher (mean of 47% for 7 cases). The
average frequency of IgG-EA rosette-
forming cells in 5 cases of B-PLL was
36%.
Complement receptors and complement-
receptor subtypes.-Complement receptors
were demonstrable in all cases of CB/CC
tested. In 9 cases, a mean of 48% of the
suspended cells showed rosette formation
with EACmouse. Complement receptor
subtypes were analysed in all 14 cases.
The mean percentage of EAC3b-binding
cells was 33% and of EAC3d-binding
cells 38%. The EACmouse rosette assay in
7 cases of B-CLL revealed a mean of
69.9% rosette-forming cells. Complement-
receptor subtypes were specified in all
15 cases. There was a predominance of
C3d receptor-bearing cells (mean 66%)
over C3b receptor-bearing cells (mean
22.9%). Complement receptors were
detectable in all tested cases of B-PLL.
There was considerablevariation, however,
in the number of EAC-binding cells when
the complement-receptor subtypes were
analysed. Nevertheless, the average num-
ber of C3b+ cells exceeded the number of
cells with C3d receptors.
Sheep erythrocyte rosetteformation.-The
proportion of sheep E-rosette-forming
cells was usually large (mean 22%) in the
14 cases of CB/CC. The rosette-forming
cells were cytologically identifiable as
small lymphocytes. In the 15 cases of
B-CLL, a mean of 8% of the suspended
cells formed rosettes with sheep E. In
B-PLL, the proportion of sheep E-
rosette-forming cells depended on the
number of prolymphocytes in the blood,
and was thus usually small (mean 10%).
The lymphnode cell suspension from one
case of B-PLL revealed 18% rosette-
forming cells.
DISCUSSION
The main morphological criterion ofthe
lymphoma discussed here is the nuclear
polymorphism of the tumour cells. The
nuclei are irregularly shaped, with deep
clefts or anguli, which are most easily
recognizable on histological sections and
on cytocentrifuge slides prepared from
tumour-cell suspensions. Electron-micro-
scopical studies have confirmed that the
irregular nuclear shape is not an artifact
(Kaiserling, 1978). The nuclear chromatin
is less condensed than that of lympho-
cytes. Up to 3 small central nucleoli are
visible. With Giemsa staining, the cyto-
plasm is often too faint to be visible. The
tumour cells range in size from small to
intermediate. Comparing the cytological
features of these tumour cells with those
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of the various cells present in non-
malignant lymphoid tissue, it is obvious
that the tumour cells are most similar in
morphology to centrocytes of reactive
germinal centres. The tumour shows a
diffuse growth pattern in all but rare
cases. In those exceptional cases, a
vaguely nodular pattern is recognizable,
especially with Gomori staining. All the
cases in the present investigation showed
a diffuse growth pattern.
Thelymphomas with the above morpho-
logical characteristics revealed remarkably
uniform immunological features, whether
tumour cells from lymph nodes or from
peripheral blood were examined. After
labelling of the cells with fluorescent
anti-Ig sera, the usually strong fluor-
escence reflected relatively large amounts
of SIg. In 6/9 cases, the staining pattern
was clearly monotypic (positive for only
one light-chain type), in agreement with
previously reported data on 14 cases
(Stein, 1978). In that study, the SIg
staining was restricted to one light-chain
type in only 9 of the 14 cases. Other
authors have reported large amounts of
SIg restricted to one light-chain type in
all or most cases of ML poorly differen-
tiated (Hopper, 1974; Preud'Homme etal.,
1974; Aisenberg & Long, 1975; Brouet
et al., 1975) ML intermediate differen-
tiation (Berard et al., 1978) or follicular-
centre cell (FCC) lymphoma, small and
large cleaved, diffuse (Leech et al., 1975).
At least some of the cases described by
those authors are equivalent to the type of
lymphoma under discussion here. Like
the tumour cells of CB/CC (follicular
lymphoma), those of the lymphoma type
described here bore a relatively dense
layer of SIg. Reactive GCC usually do not
show such a high density of SIg. The
reason for this discrepancy has not yet
been found.
In all cases stained for CIg by the PAP
method, the tumour cells were consistently
negative, indicating no synthesis of
secretory Ig. This finding concurs with
the lack of secretory organelles (ergasto-
plasm) in the tumour cells (Kaiserling,
1978) and the usually decreased levels of
serum Ig (Stein, 1976).
In the 4 cases tested, Ia-like antigen
was demonstrable in a variable proportion
of the cells. The presence of Ia-like
antigen and SIg proves the B-cell nature
of the tumour cells.
The proportion of mouse E-rosette-
forming cells was consistently small, even
after treatment of the tumour cells with
neuraminidase. This finding agrees with
data on cases of lymphosarcoma-cell
leukaemia reported by Catovsky et al.
(1976); lymphosarcoma-cell leukaemia
might be roughly equivalent to the type
of lymphnode tumour described in this
report. In their inability to bind mouse E,
the tumour cells resemble centrocytes of
reactive germinal centres (own un-
published data).
Complement receptors were expressed
in all 13 cases analysed. Complement-
receptor subtypes (receptors for C3b and
C3d) were specified in 11 ofthose, in all of
which both complement-receptor sub-
types could be demonstrated on the
tumour cells. The percentages of C3b
receptor-positiveandC3dreceptor-positive
tumour cells were about equal in all but
one case. In that exception, there was a
definite preponderance of EAC3b-reactive
cellsoverEAC3d-reactive cells. These find-
ings, obtained on cell suspensions, agree
with our earlier data (Stein & Tolksdorf,
1979) and with the demonstration of
complement-receptor subtypes on frozen
tissue sections from 4 cases. In 3 of those
bothEAC3b and EAC3d, andinthefourth,
only EAC3b adhered to the sections. We
may conclude from the results presented
here that (a) the simultaneous presence of
both complement-receptor subtypes is
highly characteristic of the lymphoma
cells under discussion, and (b)occasionally,
C3d receptors are decreased in number,
or even absent.
The presented data on complement-
receptor subtypes are interesting in con-
nection with our recent observations on
the occurrence and distribution ofcomple-
ment receptor subtypes in follicular
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hyperplasia (Stein et al., 1978b). We found
that EAC(3d usually adhered to germinal
centres and the follicular mantle, whereas
EAC3b adhered not only to germinal
centres and the follicular mantle, but also
to parafollicular areas and, in many
instances, to interfollicular areas, but
spared the T-dependent paracortical zone.
In rare instances, however, we observed
germinal centres with small areas to which
only EAC3b and no, or reduced amounts
of, EAC3d were bound. Cytological
evaluation of EAC3b- and EAC3d-
binding tonsil cells on cytocentrifuge
slides confirmed that cells exhibiting the
typical features of GCC usually express
both complement-receptor subtypes.
Taking the data on follicular hyperplasia
into consideration, we may conclude that
the lymphomas showing both complement
receptor subtypes are most likely derived
from GCC. The cells of the 2 cases that
showed a predominance or exclusive
expression of C3b receptors might be
related to GCC that express only C3b and
no, or only reduced amounts of, C3d
receptors.
Further evidence of a relationship
between the type of lymphoma cell
described here and GCC has been provided
by electron-microscopical investigations
(Kaiserling, 1978). In 12/20 isomorphic
cases, dendritic reticulum cells were
demonstrable among the tumour cells.
Dendritic reticulum cells appear to be
restricted to the lymphnode cortex, in
which the germinal-centre reaction takes
place (Milanesi, 1965; Mitchell & Abbot,
1965; Nossal et al., 1968; Lennert &
Niedorf, 1969; Veldman, 1970).
In conclusion, both the morphological
and the immunological findings suggest
that the type oflymphoma described here
is a separate entity. It appears to be a
monoclonal proliferation of the GCC
that we call "centrocytes", which led to
the term "ML centrocytic".
Centrocytic lymphoma, as it is de-
scribed here, is not found as a separate
entity in other classifications. In former
German and other European classification
concepts, it was often grouped together
with other lymphomas under the term
"lymphocytic lymphosarcoma" and the
leukaemic cases were placed under
"leukosarcomatosis" or sometimes "CLL".
According to Rappaport's (1966) classi-
fication, cases of centrocytic lymphoma
would be diagnosed as either ML lympho-
cytic, well differentiated, or ML lympho-
cytic, poorly differentiated. In the
classification of Lukes & Collins (1975),
centrocytic lymphoma is included among
the FCC lymphomas, small and large
cleaved types. Thus, Lukes & Collins'
interpretation comes close to our own. In
contrast to our concept, however, they
define the small and large cleaved types
of FCC lymphoma as those malignant
lymphomas in which the number of
cleaved cells (centrocytes) exceeds the
number of non-cleaved cells (centro-
blasts) by a factor of 3. The small and
large cleaved types of FCC lymphoma of
Lukes & Collins are thus composed either
of a mixture of centroblasts and centro-
cytes with a predominance of centro-
cytes, or of centrocytes alone. In other
words, FCC lymphomas of the cleaved
type include both CB/CC and centrocytic
lymphoma of our classification concept.
That explains why most small and large
cleaved FCC lymphomas of Lukes &
Collins exhibit a follicular growth pattern.
In contrast, centrocytic lymphoma usually
has a diffuse growth pattern.
Berard et al. (1978) have distinguished
a type of malignant lymphoma, which
they called "ML intermediate differen-
tiation" (MLID), that shares some
morphological and immunological fea-
tures with centrocytic lymphoma. The
authors described the growth pattern of
MLID as usually diffuse, but sometimes
vaguely nodular. The tumour cells were
small and relatively uniform in appear-
ance. They showed a high density of SIg,
and most cells had complement receptors,
as do centrocytic lymphoma cells. In
contrast to our cases, however, in which
nearly all tumour cells had more or less
cleaved nuclei, the nuclei in MLID were
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described as a variable mixture of small
round ones (resembling those of well-
differentiated lymphocytic lymphoma or
B-CLL) and cleaved ones (like those of
follicular lymphoma). Thus, the term "ML
intermediate differentiation" is applied to
a type of lymphoma that consists of 2
different types of cells. Three out of the
6 cases of MLID studied by Berard and
co-workers were alkaline-phosphatase-
positive. We did not perform the alkaline
phosphatase reaction in our series of
cases. It will be necessary to perform
further studies to clarify the relationship
between MLID and centrocytic
lymphoma.
A comparison of the properties of
centrocytic lymphoma with those of
CB/CC, or follicular lymphoma, which is
now generally thought to be a GCC-
derived lymphoma (Jaffe et al., 1974;
Lukes & Collins, 1975; Stein et al., 1978b)
justifies separating these types of
lymphoma. Briefly, CB/CC consistently
differs from centrocytic lymphoma in the
composition of the tumour; CB/CC is a
mixed proliferation of centrocytes (pre-
dominant in number) and centroblasts.
CB/CC also differs from centrocytic
lymphoma in the follicular growth
pattern, the presence of a number of
mouse E-rosetting cells, and the presence
of a relatively large proportion of T cells
(see Table III). There is also a difference
in prognosis: patients with CB/CC survive
longer than patients with centrocytic
lymphoma (Brittinger, 1978).
Centrocytic lymphoma is also clearly
distinguishable from B-CLL. In B-CLL,
the predominant type of cell resembles
blood lymphocytes, which usually have a
round or oval, and relatively regularly
shaped nucleus. Among the lymphocytes,
there are always some medium-sized cells
and a few large blast cells with a central
nucleolus; the medium-sized and large
cells are often grouped in clusters and
thus produce a so-called pseudofollicular
pattern. Immunologically, B-CLL cells
differ from the cells of centrocytic
lymphoma in the usually low density of
SIg, the large proportion of mouse E-
TABLE III. Immunological findings in centrocytic lymphoma, centroblastic/centrocytic
lymphoma, chronic lymphocytic leukaemia of B type, and prolymphocytic leulkaemia of
B type
IgG-Fc-R
SIg Clg* EA Agg
Centrocytic lymphoma
No. of cases 10
Mean(%)* 82-5
s.d. 14-1
9
0
10
20-3
22 -4
1
20
Complement receptors
EACmo EAC3b EAC3d
2
74
Mouse-E-R
Ly LyN
11 11 10 9
60-5 56-6 1 1 4-9
19-7 27-9 2-5 7-1
Ia Sheep-E-R
4
71 -3
16-4
11
7-4
4-5
Centroblastic/centrocytic lymphoma
No. ofcases 13 13 12 8
Mean (%) 67-3 3 15 10-8
s.d. 20-1 18-4 12
Chronic lymphocytic leukaemia
No. of cases 12 15 14 7
Mean (%) 60-6 0 19-2 47
s.d. 24-6 19-6 23 7
Prolymphocytic leukaemia
No. ofcases 5
Mean (%)
s.d.
86-8
16-5
2 5 0
0 36-8
33-6
9 14 14 14 13 3 14
48-6 33-4 38-1 15-7 29-6 62-7 22
15-9 13-7 16-3 17-2 19 11-7 7-7
7 15 15 15 14
69-9 22-9 66-2 44-1 62 8
13-2 15-3 15 21-8 17-2
1 5 5 5 5
80 40-6 29-4 2-6 7-2
29-1 27-0 4-7 10-1
3 15
48-7
15-5
2
60
8-3
2-8
5
10-2
6-1
* No. of cases containing CIg+ tumour cells is shown instead of mean %.
Abbreviations as in Table II.
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rosetting cells, and the predominance of
C3d receptor-bearing cells over C3b
receptor-bearing cells (see Table III).
Furthermore, B-CLL and centrocytic
lymphoma differ in clinical behaviour and
prognosis (Brittinger, 1978).
B-PLL is the only disorder that is
not always clearly distinguishable from
centrocytic lymphoma by immunological
methods. The tumour cells of B-PLL
bear a dense layer of SIg, lack CIg,
express a variable number of complement
receptors of both subtypes and lack
mouse E-receptors; B-PLL thus resembles
centrocytic lymphoma immunologically
(see Table III). B-PLL has to be
differentiated from centrocytic lymphoma
by cytological criteria and clinical be-
haviour, or by detection of tartrate-
resistant acid phosphatase activity.
Centrocytic lymphoma is easily distin-
guishable morphologically from all other
types of non-Hodgkin's lymphoma of
B-cell type that were not discussed here,
viz.: lymphoplasmacytic/-cytoid lym-
phoma (LP immunocytoma), lympho-
blastic lymphoma of the Burkitt type
and ofthe unclassified type, and immuno-
blastic lymphoma (large-cell lymphoma).
It should be mentioned, however, that
the morphological differential diagnosis
between centrocytic lymphoma and
lymphoblastic lymphoma of the con-
voluted-cell type is sometimes difficult,
because the "convolutions" of the nuclei
in lymphoblastic lymphoma of the con-
voluted-cell type are not always clearly
distinguishable in histological sections
from the "cleavage" or "indentations"
of the nuclei in centrocytic lymphoma.
In such cases, these 2 types of lym-
phoma can be clearly differentiated by
the acid-phosphatase reaction, or the
more reliable immunological assays:
lymphoblastic lymphoma of the con-
voluted-cell type shows focal acid-
phosphatase activity and is SIg- and
sheep E-rosette-positive in most cases,
and is human T-lymphocyte antigen-
positive in all cases (Stein et al., 1976,
1979; Thiel et al., 1977).
In summary, the morphological and
immunological data presented here and
compared with those on other known
entities, not only justify, but compel the
separation of the type of lymphoma
described in this paper as a distinct
entity. Since the tumour cells are highly
similar to centrocytes ofreactive germinal
centres (cleaved nuclei, presence of SJg
and both complement-receptor subtypes,
and absence of receptors for mouse E) we
consider this lymphoma entity to be
closely related to, or even derived from,
centrocytes.
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